e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Assessment of airway inflammation by exhaled gases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The impact of fractional exhaled nitric oxide (FeNO) measurement on treatment decision making in the specialist care of established asthma
C. LaForce, N. Herje, P. Dorinsky (Raleigh, Morrisville, United States Of America)
Source:
Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Session:
Assessment of airway inflammation by exhaled gases
Session type:
Poster Discussion
Number:
3556
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. LaForce, N. Herje, P. Dorinsky (Raleigh, Morrisville, United States Of America). The impact of fractional exhaled nitric oxide (FeNO) measurement on treatment decision making in the specialist care of established asthma. Eur Respir J 2013; 42: Suppl. 57, 3556
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Cost savings using fractional exhaled nitric oxide (FeNO) testing in asthma management by specialists
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Opinions towards the implementation of spirometry and exhaled nitric oxide testing in children under investigation for asthma in primary care
Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools
Year: 2018
Economic evaluation of fractional exhaled nitric oxide (FENO) for the management of adult asthma in Spain
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Does the measurement of exhaled nitric oxide before and after specific inhalation challenges improve the diagnosis of occupational asthma?
Source: International Congress 2019 – Occupational lung diseases: from diagnostic techniques to classical and novel causes
Year: 2019
Audit of the impact of introducing exhaled nitric oxide (FE
NO
) monitoring to an adult asthma clinic in a district general hospital
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011
Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma?
Source: Eur Respir J, 55 (5) 1901879; 10.1183/13993003.01879-2019
Year: 2020
Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) for predicting short-term treatment effect
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Using fractional exhaled nitric oxide to guide step-down treatment decisions in asthma: practical considerations
Source: Eur Respir J, 56 (2) 2002809; 10.1183/13993003.02809-2020
Year: 2020
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019
Year: 2019
The assessment of exhaled nitric oxide fraction in monitoring asthma control: How to raise the clinical relevance?
Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Year: 2010
Treatment decisions with an exhaled nitric oxide (eNO)-based algorithm vs a symptoms-based algorithm for asthma in pregnancy
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018
Meta analysis of asthma exacerbation rates in adult and pediatric asthmatics managed using fractional exhaled nitric oxide versus standard clinical parameters alone
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
Personalised exhaled nitric oxygen fraction (
F
ENO
)-driven asthma management in primary care: a
F
ENO
subgroup analysis of the ACCURATE trial
Source: ERJ Open Res, 6 (3) 00351-2019; 10.1183/23120541.00351-2019
Year: 2020
Educational intervention decreases exhaled nitric oxide in farmers with occupational asthma
Source: Eur Respir J 2007; 30: 545-548
Year: 2007
Clinical utility of fractional exhaled nitric oxide in severe asthma management
Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019
Year: 2020
Practical utility of portable exhaled nitric oxide (eNO) readings to aid in asthma management plans – a district general hospital (DGH) experience
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Usefulness of fraction of exhaled nitric oxide and asthma management questionnaires in predicting a future risk of asthma exacerbation
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Clinical usefulness of fractional exhaled nitric oxide (FeNO) as a marker of long-term asthma control
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept